Our state-of-the-art insertable cardiac monitor (ICM) sets a new standard for continuous monitoring and automatic arrhythmia detection. Assert-IQ ICM is the longest lasting Bluetooth® ICM,1-8 that provides true value with reduced false positives, simplified clinic workflows, and reduced data burden9-12 – all within a small device that integrates seamlessly into patients’ lives.
With the Assert-IQ ICM, you can diagnose AF three times faster than external cardiac monitoring methods for cryptogenic stroke patients.13 Explore this and all the benefits of faster AF diagnosis.
Advanced algorithms assist in reducing clinic data while maintaining sensitivity to detect true events. Designed to build user confidence and provide reassurance to your patients, the algorithm enhancements have been proven to reduce false detection and data burden as shown below:
Assert-IQ ICM’s advanced algorithms reduce false detections by 98.7% for AF and Pause, while maintaining 97.7% of true EGMs.9,10
When compared to the latest version of LINQ II‡,
Assert-IQ ICM’s AF algorithm reduces data burden by 21% while maintaining sensitivity.*,9,15,16
Assert-IQ ICM provides a holistic view of cardiovascular health with new IQ Insights that show trends and timelines to empower data-driven decisions.
Premature Ventricular Contractions (PVCs)
Leading PVC detection algorithm offers the ability to capture consecutive events, including couplets and triplets.18
Elevated Heart Rate with and without Activity
An ICM first.1-8
Body Position & Posture Changes
Assess patient factors to help adjudicate episodes.
DirectTrend™ Viewer
Assess AF Burden, PVCs, Activity Trends, and MORE!
While other devices use a standard set of criteria for all types of arrhythmias, Assert-IQ ICM uses Key Episode** technology that tailors data to the arrhythmia type. This technology gives you the flexibility to toggle between viewing all episodes or 3 Key Episodes** that are most critical to your patient’s care.
Assert-IQ ICM empowers you and your clinic to take a more personalized approach to patient management with valuable insights designed to help inform treatment decisions.
| Assert-IQ™ ICM | Medtronic Reveal LINQ‡ | Medtronic LINQ II‡ | |
|---|---|---|---|
| Arrhythmia Type | Key Episode Selection: Up to 3 EGMs per day, per arrhythmia type1 | Selection: One EGM per day based on wireless data priority2 | Selection: Three auto episode EGMs per day per arrhythmia type3 |
| Atrial Fibrillation | 1. Longest episode | One EGM per Patient manual | Same standard criteria set 1. First episode |
| Tachycardia | 1. Longest episode | ||
| Bradycardia | 1. Longest episode | ||
| Pause | 1. Longest episode |
† As of 12.31.23. Reveal LINQ‡ User Manual, LINQ II‡ User Manual, LUX-Dx‡ User Manual, LUX-Dx II/II+‡ User Manual, BIOMONITOR III‡ User Manual, BIOMONITOR IIIm‡ User Manual, and BIOMONITOR IV‡ User Manual.
* As of 12.31.22, LINQ II‡ with AccuRhythm‡ AI. EGM burden comparison is based on two independent, random, real-world data sets. Patient characteristics and device programming may differ.
** Key Episodes is a feature of Merlin.net™ PCN
™ Indicates a trademark of the Abbott group of companies.
‡ Indicates a third -party trademark, which is property of its respective owner.
Bluetooth and Bluetooth logo are registered trademarks of Bluetooth SIG, Inc.
Additional references
MAT-2303992 v8.0
Stay Connected